Skip to content

Study of effects of nasal dexmedetomidine and midazolam before operation in children

Comparative study between nasal atomized dexmedetomidine and midazolam as premedication in children - na

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063804
Enrollment
60
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Intranasal atomized midazolam: Administration of atomized midazolam intranasally attached to a syringe of 1ml at a dose of 0.2 mg/Kg with the drug taken from the ampule of 5mg/ml for pr

Sponsors

Pt BD Sharma University of Health Sciences Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children belonging to either sex age between 2 t0 8 year with ASA physical status 1 and 11 scheduled to undergo various elective surgical procedures

Exclusion criteria

Exclusion criteria: 1 children with systemic illness 2 parent refusal 3 known allergic to midazolam and dexmedetomidine

Design outcomes

Primary

MeasureTime frame
comparative study between intranasal atomized midazolam and dexmedetomidineTimepoint: outcome will be accessed after 30 minute of drug administration

Secondary

MeasureTime frame
1 sedation score 2 parent separation 3 mass acceptanceTimepoint: accessed after 30 minute of drug administration

Countries

India

Contacts

Public ContactSusheel Kumar

Department of Anesthesia PGIMS Rohtak

susheelchhoker@gmail.com8708896174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026